COVID-19 associated vasculitis: A systematic review of case reports and case series.
COVID-19
COVID-19, Coronavirus disease of 2019
IgA vasculitis
IgA, Immunoglubulin A
Kawasaki disease
Leukocytoclastic vasculitis
SARS-C0V, Severe Acute Respiratory Syndrome Coronavirus 2
SARS-CoV-2
Vasculitis
Journal
Annals of medicine and surgery (2012)
ISSN: 2049-0801
Titre abrégé: Ann Med Surg (Lond)
Pays: England
ID NLM: 101616869
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
14
12
2021
revised:
31
12
2021
accepted:
06
01
2022
pubmed:
19
1
2022
medline:
19
1
2022
entrez:
18
1
2022
Statut:
ppublish
Résumé
Vasculitis is one of the complications of COVID-19. We conducted a systematic review analysing the association of COVID-19 with vasculitis. We searched Google Scholar and PubMed from December 1, 2019, to October 11, 2021. The review included 8 studies (7 case reports and 1 case series) reporting 9 cases of vasculitis secondary to COVID-19. The mean age was 29.17 ± 28.2 years, ranging from 6 months to 83 years. The male to female ratio was 4:5. Maculopapular, violaceous, papular and erythematous rash were common. Heparin(n = 2), corticosteroids (n = 6) (methylprednisolone) and intravenous immunoglobulin (n = 4) were prescribed in these patients. Significant clinical improvement was observed in 8 out of 9 patients. One person died during treatment. Our study discusses vasculitis as one of the complications of COVID-19. Furthermore, the pathophysiology, clinical presentation, and management of COVID-19 associated vasculitis is discussed.
Identifiants
pubmed: 35039779
doi: 10.1016/j.amsu.2022.103249
pii: S2049-0801(22)00009-7
pmc: PMC8754903
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
103249Informations de copyright
© 2022 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.
Déclaration de conflit d'intérêts
The authors have no conflict of interests to declare.
Références
Mediterr J Rheumatol. 2020 Sep 21;31(Suppl 2):268-274
pubmed: 33196004
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e536-e537
pubmed: 32453865
Pediatr Ann. 2021 Jan 1;50(1):e44-e48
pubmed: 33450039
Autoimmun Rev. 2017 Dec;16(12):1246-1253
pubmed: 29037908
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
Lancet. 2002 Oct 19;360(9341):1197-202
pubmed: 12401245
Rheumatol Int. 2020 Dec;40(12):2105-2115
pubmed: 32936318
J Thromb Thrombolysis. 2020 Oct;50(3):499-511
pubmed: 32700024
BMJ. 2017 Sep 21;358:j4008
pubmed: 28935701
BMJ Case Rep. 2020 Oct 29;13(10):
pubmed: 33122236
Ann Med Surg (Lond). 2021 Nov;71:102898
pubmed: 34659743
J Thromb Thrombolysis. 2020 Jul;50(1):54-67
pubmed: 32415579
PLoS One. 2012;7(6):e38998
pubmed: 22723916
JBI Evid Synth. 2020 Oct;18(10):2127-2133
pubmed: 33038125
Am J Emerg Med. 2021 Jan;39:253.e1-253.e2
pubmed: 32631771
Semin Immunopathol. 2021 Oct;43(5):729-738
pubmed: 34170395
Int J Surg. 2021 Apr;88:105906
pubmed: 33789826
Hosp Pediatr. 2020 Jun;10(6):537-540
pubmed: 32265235
Travel Med Infect Dis. 2021 Nov-Dec;44:102148
pubmed: 34454090
Curr Rheumatol Rep. 2020 Sep 13;22(10):75
pubmed: 32924089
Rheumatology (Oxford). 2017 Aug 1;56(8):1358-1366
pubmed: 28444335
Arthritis Rheumatol. 2020 Nov;72(11):1952-1953
pubmed: 32633104
Nat Rev Rheumatol. 2020 Jul;16(7):391-405
pubmed: 32457494
Am Fam Physician. 2020 Aug 15;102(4):229-233
pubmed: 32803924
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e541-e542
pubmed: 32441876
Acta Derm Venereol. 2017 Nov 15;97(10):1160-1166
pubmed: 28654132